Operating Profit Margin
since 2005
Calculation
Abbott Laboratories, operating profit margin, long-term trends, calculation
| Operating profit margin | = | 100 | × | Operating earnings1 | ÷ | Net sales1 | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 15.48% | = | 100 | × | 5,357 | ÷ | 34,608 |
| Dec 31, 2019 | 14.21% | = | 100 | × | 4,532 | ÷ | 31,904 |
| Dec 31, 2018 | 11.94% | = | 100 | × | 3,650 | ÷ | 30,578 |
| Dec 31, 2017 | 6.30% | = | 100 | × | 1,726 | ÷ | 27,390 |
| Dec 31, 2016 | 15.27% | = | 100 | × | 3,185 | ÷ | 20,853 |
| Dec 31, 2015 | 14.05% | = | 100 | × | 2,867 | ÷ | 20,405 |
| Dec 31, 2014 | 12.84% | = | 100 | × | 2,599 | ÷ | 20,247 |
| Dec 31, 2013 | 12.03% | = | 100 | × | 2,629 | ÷ | 21,848 |
| Dec 31, 2012 | 20.28% | = | 100 | × | 8,085 | ÷ | 39,874 |
| Dec 31, 2011 | 14.81% | = | 100 | × | 5,752 | ÷ | 38,851 |
| Dec 31, 2010 | 17.31% | = | 100 | × | 6,088 | ÷ | 35,167 |
| Dec 31, 2009 | 20.27% | = | 100 | × | 6,236 | ÷ | 30,765 |
| Dec 31, 2008 | 19.28% | = | 100 | × | 5,694 | ÷ | 29,528 |
| Dec 31, 2007 | 17.67% | = | 100 | × | 4,579 | ÷ | 25,914 |
| Dec 31, 2006 | 9.09% | = | 100 | × | 2,042 | ÷ | 22,476 |
| Dec 31, 2005 | 19.53% | = | 100 | × | 4,362 | ÷ | 22,338 |
Based on: 10-K (filing date: 2021-02-19), 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-19), 10-K (filing date: 2007-02-23), 10-K (filing date: 2006-02-22).
1 US$ in millions
Comparison to Competitors
Abbott Laboratories, operating profit margin, long-term trends, comparison to competitors
| Abbott Laboratories | AbbVie Inc. | Amgen Inc. | Gilead Sciences Inc. | Illumina Inc. | Regeneron Pharmaceuticals Inc. | Vertex Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|
| Dec 31, 2020 | 15.48% | 24.81% | 37.70% | — | 17.91% | 42.09% | 46.03% |
| Dec 31, 2019 | 14.21% | 39.03% | 43.57% | 19.38% | 27.80% | 28.10% | 28.77% |
| Dec 31, 2018 | 11.94% | 19.49% | 45.55% | 37.83% | 26.49% | 37.77% | 20.84% |
| Dec 31, 2017 | 6.30% | 33.99% | 45.76% | 55.04% | 22.02% | 35.41% | 4.95% |
| Dec 31, 2016 | 15.27% | 36.60% | 44.74% | 58.87% | 24.48% | 27.38% | 0.58% |
| Dec 31, 2015 | 14.05% | 32.97% | 40.44% | 69.03% | 27.61% | 30.51% | -45.23% |
| Dec 31, 2014 | 12.84% | 17.09% | 32.03% | 62.37% | 27.65% | 29.74% | -119.30% |
| Dec 31, 2013 | 12.03% | 30.14% | 32.25% | 41.87% | 9.44% | 36.11% | -74.54% |
| Dec 31, 2012 | 20.28% | 31.65% | 33.52% | 42.67% | 17.48% | 33.20% | 0.15% |
| Dec 31, 2011 | 14.81% | — | 28.19% | 46.77% | 18.90% | -46.02% | 8.07% |
| Dec 31, 2010 | 17.31% | — | 37.82% | 53.62% | 23.45% | -21.23% | -485.51% |
| Dec 31, 2009 | 20.27% | — | 38.37% | 54.55% | 18.85% | -19.54% | -602.63% |
| Dec 31, 2008 | 19.28% | — | 35.50% | 52.68% | 14.04% | -37.67% | -263.65% |
| Dec 31, 2007 | 17.67% | — | 27.81% | 57.98% | -82.12% | -91.55% | -210.94% |
| Dec 31, 2006 | 9.09% | — | 27.71% | -29.32% | 20.48% | -169.68% | -105.86% |
| Dec 31, 2005 | 19.53% | — | 40.33% | 61.41% | -29.18% | -187.97% | -93.15% |
Based on: 10-K (filing date: 2021-02-19), 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-22), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-02-15), 10-K (filing date: 2012-02-21), 10-K (filing date: 2011-02-18), 10-K (filing date: 2010-02-19), 10-K (filing date: 2009-02-20), 10-K (filing date: 2008-02-19), 10-K (filing date: 2007-02-23), 10-K (filing date: 2006-02-22).